Heart failure in long-term survivors of childhood cancer – a systematic review and meta-analysis of population-based studies
DOI:
https://doi.org/10.2340/1651-226X.2025.43654Keywords:
Childhood cancer, cancer survivors, congestive heart failure, cardiotoxicity, Systematic Review and Meta-AnalysisAbstract
Background and purpose: Heart failure is a well-recognised and serious non-malignant late complication among childhood cancer survivors. The primary aim of conducting this systematic review was to identify, critically appraise and synthesise population-based studies reporting on the incidence and/or prevalence of heart failure in 5-year survivors of childhood cancer (age < 18 years).
Methods: We conducted this systematic review in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) in April 2021 (registration number: CRD42021247622) and published in June 2022. We searched databases Medline, Embase, Scopus, CINAHL, CAB International, AMED, Global Health, Psycinfo, Web of science and Google Scholar from their inception date until March 14, 2023. Screening, data extraction and quality assessment were conducted independently by two reviewers. The Effective Public Healthcare Practice Project tool was used for quality assessment.
Results: Following a comprehensive review of the 3,883 records, only four were found to be eligible for inclusion. The overall quality of the studies was evaluated as strong in two studies and moderate in the remaining two studies. A subsequent meta-analysis of three comparable studies yielded a cumulative incidence of 0.99% (95% confidence interval [CI] 0.57–1.42) over an extended period of 5.0–72.5 years (I-squared = 94.4%, p < 0.001).
Interpretation: Existing population-based studies reporting on heart failure in 5-year childhood cancer survivors are few and heterogeneous. Future population-based studies comparing heart failure incidence in childhood cancer survivors with the general population would be of significant value.
Downloads
References
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5 – a population-based study. Lancet Oncol. 2014;15:35–47.
https://doi.org/10.1016/s1470-2045(13)70548-5 DOI: https://doi.org/10.1016/S1470-2045(13)70548-5
Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary CL, et al. SEER cancer statistics review, 1975–2014. Bethesda, MD: National Cancer Institute. [cited 2025 Apr 1] Available from: https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.
https://doi.org/10.1056/nejmsa060185 DOI: https://doi.org/10.1056/NEJMsa060185
Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014;32(12):1218–27.
https://doi.org/10.1200/jco.2013.51.1055 DOI: https://doi.org/10.1200/JCO.2013.51.1055
Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100:1368–79.
https://doi.org/10.1093/jnci/djn310 DOI: https://doi.org/10.1093/jnci/djn310
Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, Dwyer M, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123–36.
https://doi.org/10.1016/S1470-2045(14)70409-7 DOI: https://doi.org/10.1016/S1470-2045(14)70409-7
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort. BMJ (Online). 2009;339:34.
https://doi.org/10.1136/bmj.b4606 DOI: https://doi.org/10.1136/bmj.b4606
Scholz‐Kreisel P, Spix C, Blettner M, Eckerle S, Faber J, Wild P, et al. Prevalence of cardiovascular late sequelae in long‐term survivors of childhood cancer: a systematic review and meta‐analysis. Pediatr Blood Cancer. 2017;64(7):e26428.
https://doi.org/10.1002/pbc.26428 DOI: https://doi.org/10.1002/pbc.26428
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106:dju244.
https://doi.org/10.1093/jnci/dju244 DOI: https://doi.org/10.1093/jnci/dju244
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895–1032. DOI: https://doi.org/10.1161/CIR.0000000000001073
https://doi.org/10.1016/j.jacc.2021.12.012 DOI: https://doi.org/10.1016/j.jacc.2021.12.012
Dolgin M. Association NYH, Fox AC, Gorlin R, Levin RI, New York Heart Association. Criteria Committee. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. Boston, MA: Lippincott Williams and Wilkins; 1994.
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118:3272–87.
https://doi.org/10.1093/cvr/cvac013 DOI: https://doi.org/10.1093/cvr/cvac013
Van Der Pal HJ, Van Dalen EC, Van Delden E, Van Dijk IW, Kok WE, Geskus RB, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012;30:1429–37.
https://doi.org/10.1200/jco.2010.33.4730 DOI: https://doi.org/10.1200/JCO.2010.33.4730
Kremer LCM, Van Dalen EC, Offringa M, Voute PA. Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review. Ann Oncol. 2002;13:503–12.
https://doi.org/10.1093/annonc/mdf118 DOI: https://doi.org/10.1093/annonc/mdf118
Volkova M, Russell R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011;7:214–20.
https://doi.org/10.2174/157340311799960645 DOI: https://doi.org/10.2174/157340311799960645
Ehrhardt MJ, Leerink JM, Mulder RL, et al. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023;24(3):e108-e120.
https://doi.org/10.1016/S1470-2045(23)00012-8 DOI: https://doi.org/10.1016/S1470-2045(23)00012-8
Chow EJ, Chen Y, Kremer LC, Breslow NE, Hudson MM, Armstrong GT, et al. Individual prediction of heart failure among childhood cancer survivors. J Clin Oncol. 2015;33(5):394–402.
https://doi.org/10.1200/jco.2014.56.1373 DOI: https://doi.org/10.1200/JCO.2014.56.1373
Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, et al. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation. 2013;128:1927–95.
https://doi.org/10.1161/cir.0b013e3182a88099 DOI: https://doi.org/10.1161/CIR.0b013e3182a88099
Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28:1308–15.
https://doi.org/10.1200/jco.2008.20.2267 DOI: https://doi.org/10.1200/JCO.2008.20.2267
Bates JE, Rancati T, Keshavarz H, Gagliardi G, Aznar MC, Howell RM, et al. Cardiac disease in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review. Int J Radiat Oncol Biol Phys. 2024;119(2):522–32.
https://doi.org/10.1016/j.ijrobp.2023.03.045 DOI: https://doi.org/10.1016/j.ijrobp.2023.03.045
Ness KK, Kirkland JL, Gramatges MM, Wang Z, Kundu M, McCastlain K, et al. Premature physiologic aging as a paradigm for understanding increased risk of adverse health across the lifespan of survivors of childhood cancer. J Clin Oncol. 2018;36(21):2206–15.
https://doi.org/10.1200/JCO.2017.76.7467 DOI: https://doi.org/10.1200/JCO.2017.76.7467
Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673–80.
https://doi.org/10.1200/JCO.2013.49.3205 DOI: https://doi.org/10.1200/JCO.2013.49.3205
Chen Y, Chow EJ, Leisenring WM, Oeffinger KC, Border WL, Meacham LR, et al. Traditional cardiovascular risk factors and individual prediction of cardiovascular events in childhood cancer survivors. J Natl Cancer Inst. 2020;112:DJZ108.
https://doi.org/10.1093/JNCI/DJZ108 DOI: https://doi.org/10.1093/jnci/djz108
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): developed by the task force on cardio-oncology of the European Society of Cardiology (ESC). Eur Heart J. 2022;43(41):4229–361.
https://doi.org/10.1093/eurheartj/ehac244 DOI: https://doi.org/10.1093/eurheartj/ehac244
Avagimyan A, Fogacci F, Pogosova N, Kakrurskiy L, Kogan E, Urazova O, et al. Diabetic cardiomyopathy: 2023 update by the International Multidisciplinary Board of Experts. Curr Probl Cardiol. 2023:102052.
https://doi.org/10.1016/j.cpcardiol.2023.102052 DOI: https://doi.org/10.1016/j.cpcardiol.2023.102052
Rothman KJ, Greenland S, Lash TL. Modern epidemiology (3rd ed.). Philadelphia, PA: Wolters Kluwer Health-Lippincott Williams & Wilkins; 2008.
Sterne JAC HM, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: assessing risk of bias in a non-randomized study. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane handbook for systematic reviews of interventions version 63 (updated February 2022). Cochrane; 2022. [cited 2025 Apr 1] Available from: www.training.cochrane.org/handbook
Szklo M. Population-based cohort studies. Epidemiol Rev. 1998;20(1):
81–90.
https://doi.org/10.1093/oxfordjournals.epirev.a017974 DOI: https://doi.org/10.1093/oxfordjournals.epirev.a017974
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349.
https://doi.org/10.1136/bmj.g7647 DOI: https://doi.org/10.1136/bmj.g7647
Berg T, Böhmer J, Nwaru BI, Karason K, Jarfelt M. Heart failure in childhood cancer survivors – a systematic review protocol. Syst Rev. 2022;11:54.
https://doi.org/10.1186/s13643-022-01929-0 DOI: https://doi.org/10.1186/s13643-022-01929-0
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283:2008–12.
https://doi.org/10.1001/jama.283.15.2008 DOI: https://doi.org/10.1001/jama.283.15.2008
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.
https://doi.org/10.1016/j.ijsu.2021.105906 DOI: https://doi.org/10.1016/j.ijsu.2021.105906
tool EPHPP. Quality assessment tool for quantitative studies. [cited 2024 Feb 1]. Available from: https://www.ephpp.ca/quality-assessment-tool-for-quantitative-studies/
Feijen E, Font-Gonzalez A, Van der Pal HJH, Kok WEM, Geskus RB, Ronckers CM, et al. Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study. J Am Heart Assoc. 2019;8:e009122.
https://doi.org/10.1161/JAHA.118.009122 DOI: https://doi.org/10.1161/JAHA.118.009122
De Baat EC, Feijen EA, Reulen RC, Allodji RS, Bagnasco F, Bardi E, et al. Risk factors for heart failure among pan-European childhood cancer survivors: a PanCareSurFup and ProCardio cohort and nested case-control study. J Clin Oncol. 2023;41:96–106.
https://doi.org/10.1200/JCO.21.02944 DOI: https://doi.org/10.1200/JCO.21.02944
Hau EM, Caccia JN, Kasteler R, Spycher B, Suter T, Ammann RA, et al. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study. Swiss Med Wkly. 2019;149:w20012.
https://doi.org/10.4414/smw.2019.20012 DOI: https://doi.org/10.4414/smw.2019.20012
Khanna A, Pequeno P, Gupta S, Thavendiranathan P, Lee DS, Abdel-Qadir H, et al. Increased risk of all cardiovascular disease subtypes among childhood cancer survivors: population-based matched cohort study. Circulation. 2019;140:1041–3.
https://doi.org/10.1161/CIRCULATIONAHA.119.041403 DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.041403
Jarfelt M, Kujacic V, Holmgren D, Bjarnason R, Lannering B. Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;49:835–40.
https://doi.org/10.1002/pbc.21289 DOI: https://doi.org/10.1002/pbc.21289
Sadurska E. Current views on anthracycline cardiotoxicity in childhood cancer survivors. Pediatr Cardiol. 2015;36:1112–9.
https://doi.org/10.1007/s00246-015-1176-7 DOI: https://doi.org/10.1007/s00246-015-1176-7
Merkx R, Leerink JM, de Baat EC, Feijen EAM, Kok WEM, Mavinkurve-Groothuis AMC, et al. Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review. J Cancer Surviv. 2022;16(2):338-52.
https://doi.org/10.1007/s11764-021-01028-4 DOI: https://doi.org/10.1007/s11764-021-01028-4
Christiansen JR, Kanellopoulos A, Lund MB, Massey R, Dalen H, Kiserud CE, et al. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2015;62:1437–43.
https://doi.org/10.1002/pbc.25492 DOI: https://doi.org/10.1002/pbc.25492
van Waas M, Neggers SJ, Raat H, van Rij CM, Pieters R, van den Heuvel-Eibrink MM. Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors. PLoS One. 2012;7:e52237.
https://doi.org/10.1371/journal.pone.0052237 DOI: https://doi.org/10.1371/journal.pone.0052237
Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, Yasui Y, et al. Cardiovascular risk factors in adult survivors of pediatric cancer – a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2010;19:170–81.
https://doi.org/10.1158/1055-9965.EPI-09-0555 DOI: https://doi.org/10.1158/1055-9965.EPI-09-0555
Lipshultz ER, Chow EJ, Doody DR, Armenian SH, Asselin BL, Baker KS, et al. Cardiometabolic risk in childhood cancer survivors: a report from the Children’s Oncology Group. Cancer Epidemiol Biomarkers Prev. 2022;31:536–42.
https://doi.org/10.1158/1055-9965.EPI-21-0360 DOI: https://doi.org/10.1158/1055-9965.EPI-21-0360
Wang X, Singh P, Zhou L, Sharafeldin N, Landier W, Hageman L, et al. Genome-wide association study identifies ROBO2 as a novel susceptibility gene for anthracycline-related cardiomyopathy in childhood cancer survivors. J Clin Oncol. 2023;41:1758–69.
https://doi.org/10.1200/JCO.22.01527 DOI: https://doi.org/10.1200/JCO.22.01527
Armenian SH, Armstrong GT, Aune G, Chow EJ, Ehrhardt MJ, Ky B, et al. Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention. J Clin Oncol. 2018;36:2135–44.
https://doi.org/10.1200/JCO.2017.76.3920 DOI: https://doi.org/10.1200/JCO.2017.76.3920
Goldberg JF, Joshi VM, Towbin JA, Ness KK, Chi X, Santucci AK, et al. Cardiovascular family history increases risk for late-onset adverse cardiovascular outcomes in childhood cancer survivors: a St. Jude lifetime cohort report. Cancer Epidemiol Biomarkers Prev. 2021;30(1):123–32.
https://doi.org/10.1158/1055-9965.epi-20-0809 DOI: https://doi.org/10.1158/1055-9965.EPI-20-0809
Barasa A, Schaufelberger M, Lappas G, Swedberg K, Dellborg M, Rosengren A. Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J. 2014;35:25–32.
https://doi.org/10.1093/eurheartj/eht278 DOI: https://doi.org/10.1093/eurheartj/eht278
Lecoeur E, Domengé O, Fayol A, Jannot A-S, Hulot J-S. Epidemiology of heart failure in young adults: a French nationwide cohort study. Eur Heart J. 2023;44:383–92.
https://doi.org/10.1093/eurheartj/ehac651 DOI: https://doi.org/10.1093/eurheartj/ehac651
Roger VL. Epidemiology of heart failure. Circ Res. 2013;113:646–59.
https://doi.org/10.1161/circresaha.113.300268 DOI: https://doi.org/10.1161/CIRCRESAHA.113.300268
Mulrooney DA, Hyun G, Ness KK, Ehrhardt MJ, Yasui Y, Gibson TM, et al. Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the childhood cancer survivor study cohort. BMJ. 2020;368:l6794.
https://doi.org/10.1136/bmj.l6794 DOI: https://doi.org/10.1136/bmj.l6794
Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study. Ann Intern Med. 2016;164:93–101.
https://doi.org/10.7326/m15-0424 DOI: https://doi.org/10.7326/M15-0424
Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer. 2011;56:825–36.
https://doi.org/10.1002/pbc.22875 DOI: https://doi.org/10.1002/pbc.22875
Faber J, Wingerter A, Neu MA, Henninger N, Eckerle S, Munzel T, et al. Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study. Eur Heart J. 2018;39(17):1555–62.
https://doi.org/10.1093/eurheartj/ehy026 DOI: https://doi.org/10.1093/eurheartj/ehy026
van Laar M, Feltbower RG, Gale CP, Bowen DT, Oliver SE, Glaser A. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study. Br J Cancer. 2014;110:1338–41.
https://doi.org/10.1038/bjc.2014.37 DOI: https://doi.org/10.1038/bjc.2014.37
Gudmundsdottir T, Winther JF, de Fine Licht S, Bonnesen TG, Asdahl PH, Tryggvadottir L, et al. Cardiovascular disease in adult life after childhood cancer in Scandinavia: a population-based cohort study of 32,308 one-year survivors. Int J Cancer. 2015;137:1176–86.
https://doi.org/10.1002/ijc.29468 DOI: https://doi.org/10.1002/ijc.29468
Kero A, Järvelä L, Arola M, Malila N, Madanat‐Harjuoja L, Matomäki J, et al. Cardiovascular morbidity in long‐term survivors of early‐onset cancer: a population‐based study. Int J Cancer. 2014;134(3):664–73.
https://doi.org/10.1002/ijc.28385 DOI: https://doi.org/10.1002/ijc.28385
Chellapandian D, Pole JD, Nathan PC, Sung L. Congestive heart failure among children with acute leukemia: a population-based matched cohort study. Leuk Lymphoma. 2019;60:385–94.
https://doi.org/10.1080/10428194.2018.1474522 DOI: https://doi.org/10.1080/10428194.2018.1474522
Stenmarker M, Mallios P, Hedayati E, Rodriguez-Wallberg KA, Johnsson A, Alfredsson J, et al. Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study). Lancet Reg Health Eur. 2024;42:100925.
https://doi.org/10.1016/j.lanepe.2024.100925 DOI: https://doi.org/10.1016/j.lanepe.2024.100925
Moskalewicz A, Martinez B, Uleryk EM, Pechlivanoglou P, Gupta S, Nathan PC. Late mortality among 5‐year survivors of childhood cancer: a systematic review and meta‐analysis. Cancer. 2024;130(10):1844–1857.
https://doi.org/10.1002/cncr.35213 DOI: https://doi.org/10.1002/cncr.35213
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Tove Berg, Jens Böhmer, Bright I. Nwaru, Kristjan Karason, Marianne Jarfelt
This work is licensed under a Creative Commons Attribution 4.0 International License.
